Polymer Manufacturer Invibio Settles Monopoly Claims
Executive Summary
The US Federal Trade Commission said the company, which supplies more than 90% of a certain type of high-quality plastic used in medical implants, used exclusivity clauses in its contracts to keep competitors out of the market and illegally maintain its monopoly. An FTC final consent order was announced July 14.